Impact of Sustained Remission on the Risk of Serious Infection in Patients With Rheumatoid Arthritis
Author:
Affiliation:
1. Amgen; Thousand Oaks California
2. DOCS Global; North Wales Pennsylvania
3. Corrona LLC; Southborough Massachusetts
4. University of Massachusetts; Worcester
5. University of Alabama at Birmingham
Funder
Immunex (a wholly owned subsidiary of Amgen)
Corrona LLC
AbbVie
Amgen
AstraZeneca
Boehringer Ingelheim
Bristol-Myers Squibb
Crescendo Bioscience
Eli Lilly
F. Hoffmann-La Roche
Genentech
GlaxoSmithKline
Horizon Pharma USA
Janssen Pharmaceuticals
Momenta Pharmaceuticals
Novartis International AG
Pfizer
UCB
Publisher
Wiley
Subject
Rheumatology
Reference25 articles.
1. Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study;Doran;Arthritis Rheum,2002
2. The risk of hospitalized infection in patients with rheumatoid arthritis;Smitten;J Rheumatol,2008
3. High disease activity is associated with an increased risk of infection in patients with rheumatoid arthritis;Au;Ann Rheum Dis,2011
4. The risk of infections associated with rheumatoid arthritis, with its comorbidity and treatment;Listing;Rheumatology (Oxford),2013
5. Increased mortality in rheumatoid arthritis;Allebeck;Scand J Rheumatol,1982
Cited by 37 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Antibiotics in inflammatory arthritis and background population one year before and after diagnosis: a nationwide drug utilization study;Rheumatology;2024-08-27
2. Low-Dose Glucocorticoids in Older Patients with Rheumatoid Arthritis: What Does the Evidence Say?;Drugs & Aging;2024-07-27
3. Predictors of serious infections in rheumatoid arthritis—a prospective Brazilian cohort;Advances in Rheumatology;2024-03-29
4. The Intersection of COVID-19 and Rheumatoid Arthritis: Shared Mechanisms, Treatment Challenges, and Potential Therapeutic Approaches;aging and disease;2024
5. Effectiveness and safety of treat-to-target strategy for methotrexate-naïve rheumatoid arthritis patients >75 years of age;Rheumatology Advances in Practice;2023-12-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3